Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AVITA Medical (RCEL) EBIT Margin (2018 - 2025)

AVITA Medical filings provide 8 years of EBIT Margin readings, the most recent being 11.31% for Q4 2025.

  • On a quarterly basis, EBIT Margin fell 19782.0% to 11.31% in Q4 2025 year-over-year; TTM through Dec 2025 was 29.14%, a 878.0% decrease, with the full-year FY2025 number at 60.01%, down 3970.0% from a year prior.
  • EBIT Margin hit 11.31% in Q4 2025 for AVITA Medical, up from 53.65% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 186.5% in Q4 2024 to a low of 154.95% in Q1 2024.
  • Median EBIT Margin over the past 5 years was 68.28% (2021), compared with a mean of 49.66%.
  • Biggest five-year swings in EBIT Margin: skyrocketed 32902bps in 2021 and later plummeted -25574bps in 2023.
  • AVITA Medical's EBIT Margin stood at 84.74% in 2021, then surged by 300bps to 169.28% in 2022, then plummeted by -151bps to 86.46% in 2023, then soared by 316bps to 186.5% in 2024, then crashed by -106bps to 11.31% in 2025.
  • The last three reported values for EBIT Margin were 11.31% (Q4 2025), 53.65% (Q3 2025), and 60.53% (Q2 2025) per Business Quant data.